GRM5 and Cognitive impairment: Since mGluR5 displays an unquestionable role in synaptic plasticity and brain physiology13,56, various studies have considered this receptor as a therapeutic target for the treatment of cognitive deficits present in normal aging, as well as in neurodegenerative disorders17,19,36,57,58.